Dr. Ian Gaudet has been with Miltenyi Biotec since 2016, currently as the Site Head at Miltenyi’s cutting-edge contract development and manufacturing organization (CDMO) in San Jose, CA, leading a team focused on rapid translation of novel cell-based therapies from bench to bedside while enabling long-term commercial feasibility. He studied Bioengineering at the University of California, San Diego, and received his doctorate in Biomedical Engineering jointly from Rutgers University and the University of Medicine and Dentistry of New Jersey. Including his tenure at Miltenyi, Dr. Gaudet has 20 years of experience in biomedical research and development.